Patient with an Idiopathic Parkinson's disease
Showing 1 - 25 of >10,000
Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)
Enrolling by invitation
- Parkinson Disease
- Treatment Adherence
-
Ankara, TurkeyAnkara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023
Idiopathic Parkinson's Progression and Dopamine Transporter
Completed
- Parkinson Disease
- Ioflupane I 123
-
Lexington, KentuckyUniversity of Kentucky Department of Neurology
Nov 16, 2022
Parkinson Disease Trial (NeuraLight)
Not yet recruiting
- Parkinson Disease
- NeuraLight
- (no location specified)
May 17, 2023
Parkinson Disease Trial (NeuraLight)
Not yet recruiting
- Parkinson Disease
- NeuraLight
- (no location specified)
Mar 29, 2023
Idiopathic Parkinson´s Disease Trial in Munich (Fasudil HCl, Placebo)
Not yet recruiting
- Idiopathic Parkinson´s Disease
- Fasudil hydrochloride
- Placebo
-
Munich, GermanyTechnische Universität München, Klinikum rechts der Isar, Klinik
Jun 27, 2023
Fatigue, Sleep and Quality of Life in Parkinson's Patients
Recruiting
- Idiopathic Parkinson's Disease
-
Niğde, TurkeyNigde Omer Halisdemir University Treaning and Research Hospital
Jan 18, 2023
Idiopathic Parkinson's Disease Trial in Shanghai (hAESCs)
Not yet recruiting
- Idiopathic Parkinson's Disease
- hAESCs
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Jan 28, 2023
HRQoL in Parkinson's Disease Patients Patients: Role of Social
Completed
- Parkinson Disease
- +5 more
-
Columbus, OhioThe Ohio State University
Oct 10, 2022
Parkinson Disease, Idiopathic Trial in Monaco (Video-oculography / Neuropsychological evaluations)
Recruiting
- Parkinson Disease, Idiopathic
- Video-oculography / Neuropsychological evaluations
-
Monaco, MonacoCentre Mémoire / Centre de Gérontologie Clinique Rainier III / P
Jan 31, 2023
Movement Disorders, Neurology, Parkinsons Disease Trial (Exablate Pallidotomy, Unilateral)
Not yet recruiting
- Movement Disorders
- +2 more
- Exablate Pallidotomy, Unilateral
- (no location specified)
Sep 13, 2022
Patients With Idiopathic and Familial Parkinson's Disease
Recruiting
- Parkinson Disease
- Study procedure
-
Ashford, United Kingdom
- +2 more
Oct 4, 2022
Idiopathic Parkinson Disease Trial (MRx0029, MRx0005)
Withdrawn
- Idiopathic Parkinson Disease
- MRx0029
- MRx0005
- (no location specified)
Apr 19, 2023
Parkinson Disease Trial in Lahore (speed dependent treadmill training on moderate speed, speed dependent treadmill training on
Recruiting
- Parkinson Disease
- speed dependent treadmill training on moderate speed
- speed dependent treadmill training on slow speed
-
Lahore, Punjab, PakistanGeneral Hospital
Jun 13, 2023
Impulsivity in Idiopathic REM Sleep Behavior Disorder
Recruiting
- Parkinson Disease
- No intervention
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
Aug 22, 2022
Parkinson's Disease Trial in San Francisco, Chicago (CERE-120: AAV2-NTN)
Completed
- Parkinson's Disease
- CERE-120: AAV2-NTN
-
San Francisco, California
- +1 more
Nov 8, 2022
DBS-FOAR Syndrome, PD Trial in China (Directional deep brain stimualtion)
Active, not recruiting
- DBS-FOAR Syndrome
- PD
- Directional deep brain stimualtion
-
Beijing, China
- +8 more
Aug 14, 2023
Idiopathic Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in León (Adipose-derived stromal vascular fraction
Completed
- Idiopathic Parkinson Disease
- Parkinson's Disease and Parkinsonism
- Adipose-derived stromal vascular fraction cells
-
León, Leon, NicaraguaHospital Escuela Oscar Danilo Rosales Arguello
Jan 24, 2023
Idiopathic Parkinson Disease Trial in Petach Tikva (NeuraLight software-based platform)
Recruiting
- Idiopathic Parkinson Disease
- NeuraLight software-based platform
-
Petach Tikva, IsraelRabin Medical Center
Aug 14, 2022
Parkinson Disease Trial (HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells))
Available
- Parkinson Disease
- HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells)
- (no location specified)
Sep 20, 2023
Idiopathic Parkinson's Disease Trial in United States (CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]), Sham
Completed
- Idiopathic Parkinson's Disease
- CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])
- Sham Surgery
-
Birmingham, Alabama
- +8 more
Nov 8, 2022
Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy
Recruiting
- Tremor Associated With Tremor Dominant Parkinson's Disease
- Unilateral thalamotomy
-
Chicago, Illinois
- +1 more
Aug 1, 2022
Balance, Activity-specific Balance Confidence and Quality of
Recruiting
- Idiopathic Parkinson's Disease
- Assessment
-
Niğde, TurkeyNigde Omer Halisdemir University Treaning and Research Hospital
Jan 8, 2023
Parkinson's Disease Trial in Charlottesville (ExAblate Transcranial System)
Active, not recruiting
- Parkinson's Disease
- ExAblate Transcranial System
-
Charlottesville, VirginiaUniversity of Virginia
Dec 19, 2022